Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Vlachos Georgios |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Bauernhofer, ET; Moser, T; Eberhard, A; Monsberger, N; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer
ANN ONCOL. 2025; 36: -ESMO Congress 2025; OCT 17-21, 2025; Berlin, GERMANY. Doi: 10.1016/j.annonc.2025.08.3135 [Poster]
Web of Science FullText FullText_MUG

 

Johannet, P; Rousseau, BJC; Vlachos, G; Foote, MBB; White, J; Patel, M; Selenica, P; Makker, V; Ellenson, L; Boroujeni, AM; Abu-Rustum, N; Mueller, J; Aghajanian, C; Weigelt, B Chromosome 1q gain defines a genomic subset of mismatch repair-deficient endometrial cancer deriving limited benefit from immune checkpoint blockade
ANN ONCOL. 2025; 36: -ESMO Congress 2025; OCT 17-21, 2025; Berlin, GERMANY. Doi: 10.1016/j.annonc.2025.08.1785 [Poster]
Web of Science FullText FullText_MUG

 

Moser, T; Bauernhofer, E; Eberhard, A; Monsberger, N; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E Beyond Blood? Assessing the prognostic and complementary role of urinary ctDNA in metastatic prostate cancer.
7th Advances in Circulating Tumor Cells meeting: “Liquid Biopsy: from Bench to Bedside”. 2025; -ACTC; SEP 24-27, 2025; Thessaloniki, GREECE. [Poster]

 

Moser, T; Bauernhofer, E; Eberhard, A; Monsberger, N; Vlachos, G; Moser, MJ; Glawitsch, L; Hammer, S; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E Beyond Blood: Can Urinary ctDNA Expand the Diagnostic Window in Advanced Prostate Cancer?
14th International Symposium on Circulating Nucleic Acids in Plasma and Serum. 2025; -CNAPS; DEC 3-5, 2025; Hong Kong, CHINA. [Poster]

 

Vlachos, G; Moser, T; Lazzeri, I; Moser, MJ; Bauernhofer, ET; Eberhard, A; Blatterer, J; Kühberger, S; Monsberger, N; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E Multimodal cfDNA profiling reveals functional homologous recombination deficiency in prostate cancer.
Advances in Circulating Tumor Cells (ACTC); SEP 24-27, 2025; Thessaloniki, GREECE. 2025. [Oral Communication]

 

Vlachos, G; Sadeghi, H; Moser, T; Lazzeri, I; Moser, MJ; Glawitsch, L; Bauernhofer, ET; Eberhard, A; Beichler, C; Blatterer, J; Kühberger, S; Monsberger, N; Terbuch, A; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E Functional Homologous Recombination Deficiency in Prostate Cancer Revealed Through Multimodal cfDNA Profiling.
14th CNAPS International Symposium, Hong Kong. 2025; -14th CNAPS International Symposium (CNAPS 2025); DEC 3-5, 2025; Hong Kong, CHINA. [Poster]

 

Moser, T; Eberhard, A; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Lazzeri, I; Ziegler, L; Bauernhofer, E; Monsberger N; Geigl, JB; Bauernhofer, T; Heitzer, E Linking liquids: cfDNA in urine and plasma as informative allies in metastasized prostate cancer.
Annual Meeting 2024. 2024; -AACR; APR 5-10, 2024; San Diego, USA. [Poster]
FullText

 

Moser, T; Vlachos, G; Heitzer, E Whole exome sequencing of cfDNA in metastatic prostate cancer.
Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. 2024. [Oral Communication]
FullText

 

Vlachos, G; Moser, T; Eberhard, A ; Bauernhofer, T; Heitzer, E ctDNA can infer Homologous Recombination Deficiency in mCRPC patients. .
Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. 2024. [Poster]

 

Vlachos, G; Moser, T; Eberhard, A; Bauernhofer, T; Heitzer, E CTDNA-based detection of homologous recombination deficiency in MCRPC patients.
ISLB. 2024; -International Society of Liquid Biopsy; NOV 23-25, 2024; Denver, USA. [Poster]
FullText

 

Vlachos, G; Moser, T; Eberhard, A; Glaswitch, L; Blatterer, J; Bauernhofer, E; Monsberger, N; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E Non-invasive detection of homologous recombination deficiency in metastatic prostate cancer patients.
Annual Meeting. 2024; -AACR 2024; APR 5-10, 2024; San Diego, USA;. [Poster]
FullText

 

Eberhard, A; Moser, T; Hammer, S; Glawitsch, L; Ziegler, L; Vlachos, G; Lang, K; Lazzeri, I; Bauernhofer, T; Balic, M; Loibner, M; Heitzer, E Development of analysis workflows for urinary cell-free DNA in malignant disease
Advances in Circulating Tumor Cells - ACTC 2023; SEP 20-23, 2023; Skiathos, Greece. 2023. [Poster]
FullText

 

Eberhard, A; Moser, T; Hammer, S; Lang, K; Faschauner, P; Vlachos, G; Belic, J; Lazzeri, I; Pichler, M; Speicher, M; Bauernhofer, T; Heitzer, E Paired analysis of blood plasma and urine reveals complementary information in prostate cancer
DocDay; FEB 9, 2023; Graz, AUSTRIA. 2023. [Oral Communication]

 

Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E Bridging urinary and plasma-based circulating tumor DNA analysis in prostate cancer.
Symposium of the Comprehensive Cancer Center. 2023; -CCC-Trio New Frontiers in Translational Oncology & Immuno-Oncology; APR 27-28, 2023; Vienna, AUSTRIA. [Poster]

 

Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E. It's a match – ctDNA in urine and plasma reveal complementary information in prostate cancer.
13th International Symposium on Minimal Residual Cancer. 2023; -ISMRC; MAY 2-4, 2023; Hamburg, GERMANY. [Poster]

 

Vlachos, G; Moser, T; Bauernhofer, T; Heitzer, E Investigating Homologous Recombination Deficiency in mCRPC through ctDNA.
ISMRC 13th International Symposium on Minimal Residual Cancer Book of Abstracts. 2023; -ISMRC 13th International Symposium on Minimal Residual Cancer; MAY 2-4, 2023;; Hamburg, GERMANY. [Poster]

 

Vlachos, G; Moser, T; Bauernhofer, T; Heitzer, E ctDNA can infer Homologous Recombination Deficiency in mCRPC patients.
6th ACTC - Advances in Circulating Tumor Cells Book of Abstracts. 2023; -6th ACTC - Advances in Circulating Tumor Cells; SEP 20-23, 2023; Skiathos, GREECE. [Poster]

 

Georgios Vlachos, Sabrina Weber, Tina Moser, Kevin Lang, Paul Faschauner, Anna Eberhard, Jelena Belic, Isaac Lazzeri, Martin Pichler, Michael Speicher, Thomas Bauernhofer, Ellen Heitzer Paired analysis of blood plasma and urine reveals complementary information in prostate cancer
Advances in circulating tumor cells ; SEP 22-25, 2021; Kalamata, GREECE. 2021. [Poster]
FullText

 

© Med Uni Graz Impressum